FTRE
Price
$6.95
Change
-$0.29 (-4.01%)
Updated
Aug 8, 10:35 AM (EDT)
Capitalization
657.39M
XNCR
Price
$7.14
Change
-$0.18 (-2.46%)
Updated
Aug 8, 11:01 AM (EDT)
Capitalization
522.08M
94 days until earnings call
Interact to see
Advertisement

FTRE vs XNCR

Header iconFTRE vs XNCR Comparison
Open Charts FTRE vs XNCRBanner chart's image
Fortrea Holdings
Price$6.95
Change-$0.29 (-4.01%)
Volume$848
Capitalization657.39M
Xencor
Price$7.14
Change-$0.18 (-2.46%)
Volume$300
Capitalization522.08M
FTRE vs XNCR Comparison Chart in %
Loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FTRE vs. XNCR commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a Buy and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (FTRE: $7.24 vs. XNCR: $7.32)
Brand notoriety: FTRE and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 86% vs. XNCR: 157%
Market capitalization -- FTRE: $657.39M vs. XNCR: $522.08M
FTRE [@Biotechnology] is valued at $657.39M. XNCR’s [@Biotechnology] market capitalization is $522.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, FTRE is a better buy in the long-term than XNCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 6 TA indicator(s) are bullish while XNCR’s TA Score has 5 bullish TA indicator(s).

  • FTRE’s TA Score: 6 bullish, 4 bearish.
  • XNCR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, FTRE is a better buy in the short-term than XNCR.

Price Growth

FTRE (@Biotechnology) experienced а +26.13% price change this week, while XNCR (@Biotechnology) price change was -12.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

XNCR is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FTRE($657M) has a higher market cap than XNCR($522M). FTRE YTD gains are higher at: -61.180 vs. XNCR (-68.146). XNCR has higher annual earnings (EBITDA): -161.68M vs. FTRE (-552.6M). XNCR has more cash in the bank: 470M vs. FTRE (102M). XNCR has less debt than FTRE: XNCR (67.8M) vs FTRE (1.29B). FTRE has higher revenues than XNCR: FTRE (2.69B) vs XNCR (127M).
FTREXNCRFTRE / XNCR
Capitalization657M522M126%
EBITDA-552.6M-161.68M342%
Gain YTD-61.180-68.14690%
P/E RatioN/AN/A-
Revenue2.69B127M2,115%
Total Cash102M470M22%
Total Debt1.29B67.8M1,897%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FTREXNCR
RSI
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
69%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
67%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 17 days ago
72%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 1 day ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
63%
Aroon
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEMFX35.25N/A
N/A
T. Rowe Price Instl Emerging Mkts Eq
OIGCX30.87N/A
N/A
Invesco Oppenheimer International Gr C
MDFSX7.79N/A
N/A
Manning & Napier Disciplined Value S
EEMGX9.26N/A
N/A
MFS Emerging Markets Equity Research R4
TFFCX70.21N/A
N/A
Touchstone Focused C

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with SYRE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
+10.03%
SYRE - FTRE
41%
Loosely correlated
-4.51%
TECH - FTRE
40%
Loosely correlated
+0.56%
XNCR - FTRE
39%
Loosely correlated
-2.27%
DNLI - FTRE
39%
Loosely correlated
-0.42%
JAZZ - FTRE
38%
Loosely correlated
+5.81%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with CRNX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-2.27%
CRNX - XNCR
62%
Loosely correlated
-2.28%
SYRE - XNCR
57%
Loosely correlated
-4.51%
BEAM - XNCR
57%
Loosely correlated
-2.40%
ERAS - XNCR
54%
Loosely correlated
+2.10%
MGNX - XNCR
54%
Loosely correlated
N/A
More